[1]
Vityala Yethindra, Ainura Dzhangazieva, Zhyldyz Kurzhunbaeva, Tugolbai Tagaev, and Furquan Nazami, “VYTR hypothesis for the prophylactic and therapeutic efficacy of GS-5734 treatment in humans with COVID-19”, Int. J. Res. Pharm. Sci., vol. 11, no. (SPL 1), pp. 19–22, Apr. 2020.